Bedrijfsoverzicht
Ispire Technology Inc. is a specialized entity dedicated to the research, development, design, commercialization, marketing, and global distribution of e-cigarettes and cannabis vaping products under its Ispire and Aspire brands. The company operates within the Consumer Defensive sector and specifically functions in the Tobacco industry, a classification that typically reflects products with established consumer demand despite regulatory scrutiny. This business model is supported by a workforce of 81 employees, indicating a lean organizational structure focused on core product operations. With a market capitalization of $100.26M and annual revenue of $96.97M, the company holds a mid-cap position in the vaping market, suggesting it is a significant but not dominant player relative to larger tobacco conglomerates. The disparity between its substantial revenue generation and its relatively small employee base implies a high degree of operational leverage or reliance on technology and supply chain efficiencies rather than extensive labor forces.
Financiële gezondheid
The company reported revenue of $96.97M for the trailing twelve months, yet this revenue resulted in a net income of $-35,508,340 and an EBITDA of $-33,978,832. The significant gap between positive revenue and deeply negative net income reveals a cost structure where expenses, likely including research and development, regulatory compliance, or operational overhead, far exceed gross margins. Free cash flow stands at $-32,467,436, which indicates that the company is currently burning cash and lacks the internal liquidity to fund operations without external financing or asset sales. The gross margin is 16.4%, which suggests that while the core product has some pricing power or cost advantage, the majority of the top-line revenue is consumed by the cost of goods sold. Operating margin is -33.9% and profit margin is -36.6%, indicating that the company is not covering its fixed costs and is losing money on every dollar of sales after all operational expenses. The company holds $17.57M in cash against $5.68M in debt, and with a debt-to-equity ratio listed as N/A due to the negative equity situation, the balance sheet appears leveraged in a traditional sense but is currently supported by significant cash reserves to cover short-term obligations. The current ratio is 1.06, which indicates that the company has just barely enough current assets to cover its current liabilities, signaling tight short-term liquidity conditions. Return on Equity is -428.6% and Return on Assets is -20.1%, metrics that reveal that management is currently destroying shareholder value and utilizing assets inefficiently to generate profit, a common trait for growth-stage companies in volatile industries like vaping.
Waarderingsbeoordeling
The valuation metrics present a complex picture with a P/E Ratio (TTM) of N/A and a Forward P/E of -43.75. The existence of a negative forward P/E ratio implies that the market expects earnings to remain negative in the near future, rendering traditional earnings-based valuation multiples inapplicable for assessing growth potential. The price-to-book ratio is -13.06, which indicates that the stock trades at a significant discount relative to its book value, often seen in distressed or turnaround situations rather than premium valuations. The price-to-sales ratio is 1.03, and the EV/EBITDA is -2.60; these alternative metrics suggest the market is pricing the company based on revenue multiples rather than profitability, as earnings are currently non-existent. The stock has a 52-week high of $3.87 and a 52-week low of $1.44. To determine the current trading position relative to this range, one must observe that the price is trading below the recent highs, reflecting the market's cautious stance on the company's profitability trajectory. The beta is 2.65, which means the stock exhibits high price volatility and is expected to move significantly more than the broader market in response to price changes or sector-specific news.
Growth & Income
Revenue growth year-over-year is -51.5%, while earnings growth is N/A due to the absence of positive earnings in the prior period for comparison. The negative revenue growth indicates a contraction in sales volume or pricing power, which is concerning for a company attempting to sustain market share in a competitive vaping landscape. Since the company has no positive earnings, the concept of earnings growing faster than revenue is moot; instead, the contraction in revenue suggests a challenging environment or strategic shift in product mix. As a non-dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, the company does not distribute cash to shareholders but retains its limited cash flow, which is currently negative, to fund operations. The overall growth and income profile is characterized by revenue contraction and a complete lack of dividend income, highlighting a focus on survival and potential future profitability rather than immediate returns to investors.